Search - tctmd.com

Displaying 21 - 40 of 210

Sort: Relevancy | Date

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Kengo Tanabe

September 22, 2018

Presentation TCT 2018

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

Presenter: Bernard R. Chevalier, Stephen G. Ellis, Patrick W. Serruys

September 22, 2018

Podcast TCTMD Talking Points

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

August 22, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Presentation TCT 2017

Case Presentations: BRS Thrombosis Within 1 Year

Presenter: Francesco Bedogni, Stephen G. Ellis, Julinda Mehilli

November 01, 2017

Presentation TCT 2017

Case Presentations: BRS Underexpansion

Presenter: Francesco Bedogni, Stephen G. Ellis, Robert-Jan van Geuns

November 01, 2017

Presentation TCT 2017

Case Presentations: BRS Embolization and Geographic Miss

Presenter: Francesco Bedogni, Stephen G. Ellis, Daniel Chamie

November 01, 2017

Presentation TCT 2017

Mechanisms of BRS Failure Within 1 Year: Insights From Cohort Studies and Randomized Trials

Presenter: Francesco Bedogni, Stephen G. Ellis

November 01, 2017

Presentation TCT 2017

Experimental Insights to BRS Failure: Similarities and Differences to Metallic DES

Presenter: Francesco Bedogni, Stephen G. Ellis, Aloke V. Finn

November 01, 2017

Presentation TCT 2017

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Presenter: Stephen G. Ellis, Takeshi Kimura, Hiram G. Bezerra

October 31, 2017

Presentation TCT 2017

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne

October 31, 2017

Presentation TCT 2017

The Potential For BRS: What Weve Learned From Pushing The Envelope

Presenter: Stephen G. Ellis, Takeshi Kimura, Corrado Tamburino

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB SCAAR

Presenter: Stephen G. Ellis, Takeshi Kimura, Stefan K. James

October 31, 2017

Presentation TCT 2017

Registry Update: BVS STEMI STRATEGY

Presenter: Stephen G. Ellis, Takeshi Kimura, Alfonso Ielasi

October 31, 2017

Presentation TCT 2017

Registry Update: IT-DISAPPEARS

Presenter: Stephen G. Ellis, Takeshi Kimura, Francesco Bedogni

October 31, 2017

Presentation TCT 2017

Registry Update: FRANCE ABSORB

Presenter: Stephen G. Ellis, Takeshi Kimura, Didier Carrié

October 31, 2017

Presentation TCT 2017

Registry Update: GABI-R

Presenter: Stephen G. Ellis, Takeshi Kimura, Holger M. Nef

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB UK

Presenter: Stephen G. Ellis, Takeshi Kimura, Mark A. de Belder

October 31, 2017

Advertisement

ABSORB Beyond 3 Years: ABSORB Japan 4-Year Data

ABSORB Beyond 3 Years: ABSORB II 5-Year Data

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

Case Presentations: BRS Thrombosis Within 1 Year

Case Presentations: BRS Underexpansion

Case Presentations: BRS Embolization and Geographic Miss

Mechanisms of BRS Failure Within 1 Year: Insights From Cohort Studies and Randomized Trials

Experimental Insights to BRS Failure: Similarities and Differences to Metallic DES

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

The Potential For BRS: What Weve Learned From Pushing The Envelope

Registry Update: ABSORB SCAAR

Registry Update: BVS STEMI STRATEGY

Registry Update: IT-DISAPPEARS

Registry Update: FRANCE ABSORB

Registry Update: GABI-R

Registry Update: ABSORB UK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content